Adults with attention-deficit/hyperactivity disorder, or ADHD, who use an extended-release medication are more likely to ...

With 15.5 million U.S. adults currently diagnosed with ADHD, there is a growing focus on warning signs of the disorder.

Trend 3: Businesses are adopting new strategies to reduce pharmacy spending and lessen the impact of drug costs on employees.

Sangamo will regain full rights to giroctocogene fitelparvovec, a gene therapy candidate for hemophilia A, after Pfizer ended ...

IROS and Halia Therapeutics’ clinical trial will explore a promising new therapy for obesity, specifically designed to ...

Life has many ups and downs, and it's normal to feel the lows from time to time. However, for some people, this sadness may ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

Verona Pharma (VRNA) stock in focus as company reports early sales for Q4 and 2024 thanks to its lung disease therapy Ohtuvayre. Read more here.

In "Beyond Anxiety," Martha Beck argues that discovering your creative calling is the antidote to an anxious existence.

By streamlining and automating administrative tasks, AI can reduce human error, improve operational efficiency and allow ...

CorMedix Inc.'s DefenCath shows considerable promise in reducing catheter-related bloodstream infections. Click here for this ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...